Is TMCI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TMCI. It does not provide personalized investment advice.

TMCI (Treace Medical Concepts, Inc. Common Stock) Stock Analysis - Financials

Treace Medical Concepts, Inc. Common Stock (TMCI) is a publicly traded Healthcare sector company. As of November 4, 2026, TMCI trades at $4.29 with a market cap of $277.70M and a P/E ratio of -4.22. TMCI moved -0.12% today. Year to date, TMCI is +70.88%; over the trailing twelve months it is -35.17%. Its 52-week range spans $1.17 to $8.87. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces TMCI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TMCI's key financials?

TMCI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TMCI recently traded at $4.29. Market cap is $277.70M. P/E ratio is -4.22. Revenue is $205.31M.

TMCI Key Metrics

Key financial metrics for TMCI
Metric	Value
Price	$4.29
Market Cap	$277.70M
P/E Ratio	-4.22
EPS	$-0.92
Dividend Yield	0.00%
52-Week High	$8.87
52-Week Low	$1.17
Volume	178.64K
Avg Volume	0
Revenue (TTM)	$205.31M
Net Income	$-59.52M
Gross Margin	79.45%

TMCI Analyst Consensus

3 analysts cover TMCI: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.

Common questions about TMCI

What are TMCI's key financials?: TMCI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TMCI recently traded at $4.29. Market cap is $277.70M. P/E ratio is -4.22. Revenue is $205.31M.
Is TMCI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TMCI. It does not provide personalized investment advice.